Methods for estimating economic benefits of surgical interventions in low-income and middle-income countries: a scoping review

被引:1
|
作者
Hilla, Amy [1 ]
Reese, Victoria [2 ]
Nonvignon, Justice [3 ]
Dolan, Carrie B. [4 ]
机构
[1] William & Mary, Econ, Williamsburg, VA USA
[2] William & Mary, Appl Math & Econ, Williamsburg, VA USA
[3] Univ Ghana, Hlth Policy Planning & Management, Legon, Ghana
[4] William & Mary, Hlth Sci, Williamsburg, VA 23185 USA
来源
BMJ OPEN | 2020年 / 10卷 / 12期
关键词
surgery; health economics; public health; COST-EFFECTIVENESS; PEDIATRIC-SURGERY; DISABILITY; HEALTH; IMPACT; KENYA;
D O I
10.1136/bmjopen-2020-039644
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Studies indicate that many types of surgical care are cost-effective compared with other health interventions in low-income and middle-income countries (LMICs). However, global health investments to support these interventions remain limited. This study undertakes a scoping review of research on the economic impact of surgical interventions in LMICs to determine the methodologies used in measuring economic benefits. Design The Arksey and O'Malley methodological framework for scoping reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews checklist were used to review the data systematically. Online databases were used to identify papers published between 2005 and 2020, from which we selected 19 publications that quantitatively examined the economic benefits of surgical interventions in LMICs. Results Majority of publications (79%) reported the use of disability-adjusted life-years (DALYs) to assess economic impact. In comparison, 21% used other measures, such as the value of statistical life or cost-effectiveness ratios, or no measure at all. 31% were systematic or retrospective reviews of the literature on surgical procedures in LMICs, while 69% either directly assessed economic impact in a specific area or evaluated the need for surgical procedures in LMICs. All studies reviewed related to the economic impact of surgical procedures in LMICs, with most about paediatric surgical procedures or a specific surgical specialty. Conclusion To make informed policy decisions regarding global health investments, the economic impact must be accurately measured. Researchers employ a range of techniques to quantify the economic benefit of surgeries in LMICs, which limits understanding of overall economic value. We conclude that the literature would benefit from a careful selection of methods, incorporating age and disability weights based on the Global Burden of Disease weights, and converting DALYs to dollars using the value of statistical life approach and the human capital approach, reporting both estimates.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol
    AbuShweimeh, Rahmeh
    Knudson, Sophie
    Chaabane, Sonia
    Pal, Shanthi Narayan
    Skidmore, Becky
    Stergachis, Andy
    Bhat, Niranjan
    BMJ OPEN, 2023, 13 (05):
  • [42] Telemedicine in Surgical Care in Low- and Middle-Income Countries: A Scoping Review
    Eyitayo Omolara Owolabi
    Tamlyn Mac Quene
    Johnelize Louw
    Justine I. Davies
    Kathryn M. Chu
    World Journal of Surgery, 2022, 46 : 1855 - 1869
  • [43] Lactational amenorrhoea among adolescent girls in low-income and middle-income countries: a systematic scoping review
    Figaroa, Martines N. S.
    Bellizzi, Saverio
    Delvaux, Therese
    Benova, Lenka
    BMJ GLOBAL HEALTH, 2020, 5 (10):
  • [44] On the Road to Better National Surgical Data in Low-Income and Middle-Income Countries
    Leather, Andrew J. M.
    Dare, Anna J.
    JAMA SURGERY, 2016, 151 (08)
  • [45] Tobacco killing in low-income and middle-income countries
    不详
    LANCET, 2012, 379 (9822): : 1172 - 1172
  • [46] Alcohol burden in low-income and middle-income countries
    Connor, Jason P.
    Hall, Wayne
    LANCET, 2015, 386 (10007): : 1922 - 1924
  • [47] Antibiotic consumption in low-income and middle-income countries
    Hamers, Raph L.
    van Doorn, H. Rogier
    LANCET GLOBAL HEALTH, 2018, 6 (07): : E732 - E732
  • [48] Cancer burden in low-income and middle-income countries
    Anandasabapathy, Sharmila
    Asirwa, Chite
    Grover, Surbhi
    Mungo, Chemtai
    NATURE REVIEWS CANCER, 2024, 24 (03) : 167 - 170
  • [49] Cancer burden in low-income and middle-income countries
    Sharmila Anandasabapathy
    Chite Asirwa
    Surbhi Grover
    Chemtai Mungo
    Nature Reviews Cancer, 2024, 24 : 167 - 170
  • [50] Statin use in low-income and middle-income countries
    Neuhann, Florian
    Kumwenda, Tapiwa
    Mahanani, Melani Ratih
    Heller, Tom
    Steffen, Hans-Michael
    LANCET GLOBAL HEALTH, 2022, 10 (07): : E954 - E954